Prof. Manfredi Rizzo
University of Palermo, Italy; University of South Carolina, USA
Prof. Rizzo studied Medicine in Italy and gained clinical and research experience over the last 25 years in many Universities in Europe, USA and the Middle East. He is Hab. Full Professor of Internal Medicine at the School of Medicine, University of Palermo, Italy and mantains a Faculty position in the USA since 2012, as Affiliate Professor of Internal Medicine at the Division of Endocrinology and Diabetes, University of South Carolina School of Medicine; currently he is medical director Novo Nordisk BAEELM. He sits on the editorial board of 14 international journals with Impact Factor (IF) and has published 285 articles in journals with IF, with 11,679 citations, and an H-Index of 60. He has been over the years Coordinator, Vice-Chairman or co-Chairman of several International Consensus and Expert Panel Documents in the fields of dyslipidemia, diabetes and the metabolic syndrome, and the recipient of many prizes and awards, including the Career Award for “achievements in research and education in the field of atherosclerosis” by the Oman Society of Lipid and Atherosclerosis (OSLA) and the International Atherosclerosis Society (IAS) in 2018.